Featured News
More News
Trainees honored at the 4th Annual Frontiers in Diabetes Research Symposium on April 24th, 2019 with Best Poster Awards!
Keren Hilgendorf, Owen Jiang, and Yunshin Jung were awarded the Best Poster Awards at the Fourth Annual Frontiers in Diabetes Research Symposium.
Drug reduces risk of kidney failure in people with diabetes, study finds
Canagliflozin, a drug approved to lower glucose levels in diabetic patients, can slow the progression of kidney disease, according to a study co-authored by a Stanford Medicine researcher.
How to Design a Better Soda Tax
An analysis of Philadelphia’s sweet-drink “sin tax” finds a flaw in the system: Many people simply drive beyond city limits to buy their pop.
SDRC member, Dr. Michael Snyder will Co-Direct the new Stanford center that will create metabolic profiles of children
Researchers from throughout Stanford Medicine are planning to study thousands of metabolites in babies, children and pregnant women to understand the origins of disease.
SDRC member, Dr. James Priest shows congenital heart defects vastly increase risk of heart problems later in life
Even a relatively simple heart defect makes a patient much more likely to develop cardiovascular disease as an adult, Stanford researchers say.
Following events at the ADA Scientific Sessions in June, a number of concerns raised regarding the ADA's professional section remain unresolved. As a result, a boycott of ADA activities has been initiated by leading figures in diabetes research. The text below includes relevant hyperlinks with further information. Those who wish to review the petition and consider whether to sign it may do so at the links provided. This information is being shared for member awareness.